The global human immunoglobulin market is anticipated to grow at a considerable CAGR of 6.4% during the forecast period (2022-2028). Increasing research & development initiatives in the discovery of innovative medications for illness management are projected to boost the market growth. To gain on the opportunity key players operating in the global human immunoglobulin market had been adopting strategies to achieve major market share. For instance, in January 2019, the US Food and Drug Administration granted Kedrion Biopharma GmbH, the license to conduct clinical research to assess the efficacy and safety of a 10% intravenous immunoglobulin in the treatment of people with primary immunodeficiency diseases (PID).
Browse the full report description of “Global Human Immunoglobulin Market Size, Share & Trends Analysis Report By Type (Liquid and Powder), and By Disease Indication (Infectious hepatitis and Measles) Forecast 2022-2028” at https://www.omrglobal.com/industry-reports/human-immunoglobulin-market
Additionally, after the COVID-19 Pandemic, the need for plasma increased rapidly, hence ensuring plasma supply and enhanced fractionation techniques to maximize yield from each liter of plasma is also supporting the growth of the market. WHO is trying to establish a national blood system across the globe capable of providing sufficient and timely supplies of safe blood and blood products to meet the transfusion needs of all patients, with well-organized and coordinated blood transfusion services, effective evidence-based and ethical national blood policies, and legislation and regulation. For instance, in 30 June 2021, the Czech Republic's national public health authority, SUKL, had granted Biotest an operating license for its eighth plasma collection center.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Type
o By Disease Indication
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- including Baxter International Inc., CSL Ltd., Grifols S.A., Kedrion Biopharma Inc., Octapharma AG, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Human Immunoglobulin Market Report Segment
By Type
By Disease Indication
Global Human Immunoglobulin Market Report Segment by Region
North America
• US
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/human-immunoglobulin-market